Ionis Pharmaceuticals | IONS - Operating Profit


Ionis Pharmaceuticals reported $-102.29M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
Alnylam Pharmaceuticals USD 112.6M 24.99M Jun/2026
Arrowhead Research USD -170.09M 28.83M Jun/2026
Astellas Pharma JPY 185.36B 136.79B Jun/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
BioMarin Pharmaceutical USD 105.6M 24.04M Jun/2026
Celltrion KRW 12.9B 822.77M Mar/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Divis Laboratories Ltd INR 11.29B 3.15B Jun/2026
Exelixis USD 248.41M 2.93M Jun/2026
Halozyme Therapeutics USD -63.72M 1.95M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -36K 444K Dec/2025
Moderna USD -815M 573M Jun/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Neurocrine Biosciences USD 219.9M 5.3M Jun/2026
Novartis USD 4.75B 515M Jun/2026
Omeros USD -35.41M 23.75M Sep/2024
OPKO Health USD -51.02M 12.7M Mar/2026
Organigram Holdings CAD -9.79M 10.33M Mar/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pfizer USD 667M 4.32B Jun/2026
Pharma Mar EUR -1.4M 2.03M Jun/2026
PTC Therapeutics USD 45.89M 127.51M Mar/2026
Qiagen NV USD 141.4M 24.77M Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026
Sartorius EUR 164M 3.3M Jun/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Ultragenyx Pharmaceutical USD -75M 141M Jun/2026
Vertex Pharmaceuticals USD 1.27B 129.9M Jun/2026
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026